BioSkryb Genomics
BioSkryb Genomics develops single-cell multiomic analysis products and bioinformatics platforms, including the BaseJumper Bioinformatics Platform and ResolveDNA amplification kits.
About BioSkryb Genomics
BioSkryb Genomics develops single-cell multiomic analysis products and bioinformatics platforms, including the BaseJumper Bioinformatics Platform and ResolveDNA amplification kits.
Products
Cloud-based bioinformatics platform for quality control (QC) analysis of whole genome sequencing data and transcriptomic analysis, enabling data processing without a high-perfor...
Installs key bioinformatics workflows to run on a user's own high-performance computing cluster.
Custom bioinformatics services available through ResolveServices, including custom AI data set generation and preparation and access to application-specific bundled workflows cu...
Single-cell and low-input DNA amplification kit providing reproducible recovery of >97% of genomes of single cells and low-input DNA samples using primary template-directed ampl...
Early release offering providing large language model (LLM)-enabled, end-to-end (E2E) workflows for genomic exploration.
Enables whole genome and transcriptome sequencing from a single cell, leveraging primary template-directed amplification (PTA) to achieve up to 97% genomic coverage with superio...
Contract single-cell sequencing service offering end-to-end solutions from cell isolation and nucleic acid amplification through NGS workflows, data analysis, and AI training da...
What customers say
“Among all the whole-genome amplification (WGA) methods we have tested, PTA-based WGA has provided the most accurate output. It reliably stays close to the original 50/50 ratio of allele frequency in heterozygous loci, minimizing allele dropout and false-positive loss of heterozygosity.”
“PTA is our method of choice if you want reproducible, efficient, and evenly amplified genomes from single cells for single nucleotide variant detection.”
“Assistant Professor, Department of Molecular, Cell, and Cancer Biology, University of Massachusetts Medical School”
Security and compliance
As reported by BioSkryb Genomics. Ask for audit reports before you buy.
- Physical safeguards
- Technical safeguards
- Administrative safeguards
Is this your company?
Claim the profile to keep facts current, answer buyers and submit evidence for the next ranking review.
Claim BioSkryb Genomics